Titelia

Zusammensetzung von Pictet - Biotech

ISIN LU0090689299 · LU0190161025 · LU0190162189 · LU0255977372 · LU0255977455 · LU0255977539

Pictet Asset Management (Europe) S.A. · 67 gemeldete Positionen · zum 30.09.2025

Fondsbericht · Nettovermögen 1,5 Mrd. $ · Zehn größte Positionen: 33,0 % des Nettovermögens · Gebühren höchstens 1,2 bis 2,9 % je nach Anteilsklasse (3) · Mit einem anderen Fonds vergleichen · Fehler melden

Positionen

RangGesellschaftWährungStückeWertGewicht
1UNITED THERAPEUTICS United StatesUSD154.90765,5 Mio. $4,40 %
2INSMED United StatesUSD443.06463,1 Mio. $4,25 %
3ARGEN-X ADR-SPONS.- NetherlandsUSD81.16358,9 Mio. $3,96 %
4REGENERON PHARMACEUTICALS United StatesUSD85.39848,5 Mio. $3,26 %
5ALNYLAM PHARMACEUTICALS United StatesUSD104.15147 Mio. $3,16 %
6NEUROCRINE BIOSCIENCES United StatesUSD334.85546,9 Mio. $3,15 %
7MADRIGAL PHARMACEUTICALS United StatesUSD98.60643,9 Mio. $2,95 %
8BIOGEN United StatesUSD289.31340,4 Mio. $2,71 %
9GILEAD SCIENCES United StatesUSD342.98538,9 Mio. $2,61 %
10MERUS NetherlandsUSD411.28338,6 Mio. $2,59 %
11PTC THERAPEUTICS United StatesUSD627.68638,4 Mio. $2,58 %
12CRINETICS PHARMACEUTICALS United StatesUSD833.46735,2 Mio. $2,37 %
13RHYTHM PHARMACEUTICALS United StatesUSD344.47935 Mio. $2,35 %
14TG THERAPEUTICS United StatesUSD938.50634,5 Mio. $2,32 %
15IONIS PHARMACEUTICALS United StatesUSD503.38332,4 Mio. $2,18 %
16REVOLUTION MEDICINES United StatesUSD686.87831,7 Mio. $2,13 %
17PROTAGONIST THERAPEUTICS United StatesUSD472.69031 Mio. $2,09 %
18AVIDITY BIOSCIENCES United StatesUSD714.50630,8 Mio. $2,07 %
19CYTOKINETICS United StatesUSD556.89630,7 Mio. $2,06 %
20CG ONCOLOGY United StatesUSD760.67129,7 Mio. $2,00 %
21SCHOLAR ROCK HOLDING United StatesUSD762.35728,8 Mio. $1,94 %
22ABIVAX FranceEUR332.85728,3 Mio. $1,90 %
23VERA THERAPEUTICS 'A' United StatesUSD872.63225,9 Mio. $1,74 %
24BRIDGEBIO PHARMA United StatesUSD491.19425,4 Mio. $1,71 %
25AXSOME THERAPEUTICS United StatesUSD204.28724,2 Mio. $1,63 %
26AKERO THERAPEUTICS United StatesUSD487.09523,2 Mio. $1,56 %
27MIRUM PHARMACEUTICALS -S- United StatesUSD303.54522,4 Mio. $1,51 %
28XENON PHARMACEUTICALS CanadaUSD559.18822,1 Mio. $1,48 %
29PICTET - SOVEREIGN SHORT-TERM MONEY MARKET USD - Z LuxembourgUSD169.62722 Mio. $1,48 %
30MINERALYS THERAPEUTICS United StatesUSD540.77821,4 Mio. $1,44 %
31AMICUS THERAPEUTICS United StatesUSD2.632.46520,9 Mio. $1,41 %
32KINIKSA PHARMA United StatesUSD524.93720,3 Mio. $1,37 %
33NEWAMSTERDAM PHARMACEUTICALS COMPANY NetherlandsUSD728.48220,2 Mio. $1,36 %
34VAXCYTE United StatesUSD572.76720 Mio. $1,34 %
35SOLENO THERAP United StatesUSD291.02419,7 Mio. $1,33 %
36KRYSTAL BIOTECH United StatesUSD109.97819,3 Mio. $1,30 %
37ARCELLX United StatesUSD235.40519,2 Mio. $1,29 %
38NUVALENT 'A' United StatesUSD212.98518,1 Mio. $1,22 %
39ENLIVEN THERP RG United StatesUSD868.23817,5 Mio. $1,18 %
40CELLDEX THERAPEUTICS United StatesUSD673.47417,4 Mio. $1,17 %
41ULTRAGENYX PHARMACEUTICAL United StatesUSD565.62917,2 Mio. $1,16 %
42VIKING THERAPEUTICS United StatesUSD669.17417,1 Mio. $1,15 %
43BIOMARIN PHARMACEUTICALS United StatesUSD308.07616,7 Mio. $1,13 %
44IDEAYA BIOSCIENCES United StatesUSD575.76415,8 Mio. $1,06 %
45INCYTE United StatesUSD182.75215,4 Mio. $1,04 %
46ACADIA PHARMACEUTICALS United StatesUSD622.78813,3 Mio. $0,89 %
47VIRIDIAN THERAPEUTICS United StatesUSD590.68912,6 Mio. $0,85 %
48AMGEN United StatesUSD43.15312 Mio. $0,81 %
49NURIX THERAPEUTICS United StatesUSD1.143.40210,6 Mio. $0,72 %
50SUMMIT THERAPEUTICS United StatesUSD494.05510,5 Mio. $0,70 %
51VERTEX PHARMACEUTICALS United StatesUSD24.2609,6 Mio. $0,65 %
52SPYRE THERAPEUTICS United StatesUSD587.0039,5 Mio. $0,64 %
53DAY ONE BIOPHARMACEUTICALS United StatesUSD1.336.9829,4 Mio. $0,63 %
54ZEALAND PHARMA DenmarkDKK127.4159,2 Mio. $0,62 %
55OLEMA PHARMACEUTICALS United StatesUSD947.3989,1 Mio. $0,61 %
56KYMERA THERAPEUTICS United StatesUSD147.0128,6 Mio. $0,58 %
57ALKERMES IrelandUSD286.2888,5 Mio. $0,57 %
58JANUX THERAPEUTICS United StatesUSD329.5567,9 Mio. $0,53 %
59IMMUNOVANT United StatesUSD367.4875,9 Mio. $0,39 %
60TERNS PHARMACEUTICALS United StatesUSD623.2264,8 Mio. $0,33 %
61CENTESSA PHARMACEUTICALS -ADR SPONS.- United KingdomUSD190.6134,6 Mio. $0,31 %
62PEPGEN United StatesUSD435.5512,1 Mio. $0,14 %
63MOONLAKE IMMUNOTHERAPEUTICS 'A' Cayman IslandsUSD70.452446.665,7 $0,03 %
64INTARCIA THERAPEUTICS PFD AA United StatesUSD40.2190 $0,00 %
65INTARCIA THERAPEUTICS PFD BB1 United StatesUSD62.4970 $0,00 %
66INTARCIA THERAPEUTICS PFD BB2 United StatesUSD387.5830 $0,00 %
67INTARCIA THERAPEUTICS PFD CC United StatesUSD25.9240 $0,00 %

Quelle: von Pictet - Biotech veröffentlichter Bericht.

Diese Tabelle herunterladen: CSV, JSON

Länderaufteilung

  • United States 85,7 %
  • Netherlands 7,9 %
  • France 1,9 %
  • Canada 1,5 %
  • Luxembourg 1,5 %
  • Denmark 0,6 %
  • Ireland 0,6 %
  • United Kingdom 0,3 %

Länder aus dem Fondsbericht. Gewichte in % des Nettovermögens.

Aufteilung nach Währung

  • USD 97,5 %
  • EUR 1,9 %
  • DKK 0,6 %

Die gemeldete Notierungswährung jeder Position.

Diese Seite zitieren

Titelia. „Zusammensetzung von Pictet - Biotech“. https://titelia.com/de/fonds/pictet-biotech